Pharmaceuticals, Biotechnology and Life Sciences
ImCheck Publishes Comprehensive Overview of the DevelopmentResults of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Vγ9Vδ2 T Cellsin Science…
COVISTIX has received CE mark and marketing authorization from FAMHP (Federal Agency for Medicines and Health Products) that enables Sorrento…
Company announcement no. 11/2021 Please see attachment. For further information please contact: Anders Mohr Christensen, Vice President Group Strategy & Investor…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK…
Studies to use genome wide functional genetic techniques to identify effective drug combinations and new drug targets for its lead…
BUFFALO, N.Y., Oct. 20, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on…
MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline on Tuesday, October 12th…
PHILADELPHIA, Oct. 19, 2021 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (the “Company”) (Nasdaq: CNTX), a women’s oncology company developing advanced…
Telix IPAX-1 Overall Survival Overall survival (to date) indicates a median 15.97 months OS, with three patients exhibiting stable disease…
LOS ANGELES, Oct. 19, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”), a privately-held clinical-stage biopharmaceutical company focusing on precision…